Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology · Nashville, TN
NPI
1659482305
Since 2006
Specialty
Psychiatry and Neurology, Neurology with Special Qualifications in Child Neurology
Code 2084N0402X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1916 Patterson St # 104
Nashville, TN, 37203
Phone (615) 320-1583
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.5M
682 prescriptions
Company payments, 2025
$3,792
From 20 companies
Medicare prescription drug claims, 2024
In 2024, the drug James A Fry prescribed most often to Medicare patients was Oxcarbazepine, with 47 prescriptions and refills. In total James A Fry wrote 682 Medicare prescriptions that cost $1.5M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-24.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Oxcarbazepine Generic | 47 | 60 | Under 11 | $3,895 |
| Xcopri Cenobamate | 41 | 45 | Under 11 | $79K |
| Trileptal Oxcarbazepine | 36 | 36 | Under 11 | $51K |
| Zonisamide Generic | 35 | 35 | Under 11 | $1,613 |
| Lamotrigine Generic | 35 | 45 | Under 11 | $918 |
| Risperidone Generic | 34 | 68 | Under 11 | $638 |
| Citalopram Hbr Citalopram Hydrobromide | 27 | 43 | Under 11 | $115 |
| Tizanidine Hcl Generic | 27 | 35 | Under 11 | $148 |
| Clonidine Hcl Generic | 26 | 38 | Under 11 | $82.1 |
| Sabril Vigabatrin | 23 | 23 | Under 11 | $871K |
| Clonazepam Generic | 22 | 22 | Under 11 | $37.38 |
| Gabapentin Generic | 20 | 20 | Under 11 | $53.31 |
| Levetiracetam Generic | 20 | 20 | Under 11 | $557 |
| Lacosamide Generic | 19 | 21 | Under 11 | $1,636 |
| Topiramate Generic | 18 | 42 | Under 11 | $232 |
Brand drugs: 188 claims; generic drugs: 483 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James A Fry $3,792 ($2,137 in general payments such as food, travel and fees and $1,655 for research) from 20 companies. The largest payer was Eli Lilly and Company with $1,655.
| Company | Payments | Amount |
|---|---|---|
| Eli Lilly and Company LLY | 1 | $1,655 |
| SK Life Science, Inc. | 19 | $501 |
| UCB, Inc. UCB.BR | 8 | $362 |
| Neurocrine BioSciences, Inc. NBIX | 8 | $268 |
| Neurelis, Inc. | 8 | $178 |
| Tris Pharma Inc | 8 | $173 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $108 |
| Catalyst Pharmaceuticals, Inc. CPRX | 4 | $91.46 |
| Corium, LLC | 6 | $90.6 |
| Jazz Pharmaceuticals Inc. JAZZ | 3 | $77.59 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.